Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Change in Accured Expenses (2012 - 2026)

Precigen (PGEN) posted quarterly Change in Accured Expenses of -$2.3 million for Q1 2026, down 288.7% year-over-year from $1.2 million in Q1 2025, and down 977.22% quarter-over-quarter from $259000.0 in Q4 2025.

Analysis

Precigen (PGEN) Change in Accured Expenses (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Change in Accured Expenses for 15 consecutive years, with -$2.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 288.7% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at $3.4 million (down 24.18% YoY), while the FY2025 annual figure was $6.9 million, up 118.41% from the prior year.
  • Change in Accured Expenses fell to -$2.3 million in Q1 2026 per PGEN's latest filing, from $259000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $5.4 million in Q3 2023 and bottomed at -$2.8 million in Q4 2023.
  • Historically, Change in Accured Expenses has averaged $412176.5 across 5 years, with a median of -$126000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 366.01% — and 2024, when it surged 1214.69%.
  • Precigen's Change in Accured Expenses stood at -$939000.0 in 2022, then slumped by 202.24% to -$2.8 million in 2023, then jumped by 163.67% to $1.8 million in 2024, then slumped by 85.67% to $259000.0 in 2025, then sank by 977.22% to -$2.3 million in 2026.
  • Business Quant data shows PGEN's Change in Accured Expenses at -$2.3 million in Q1 2026, $259000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 7.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.53 Mn
Mar 31, 2026 -2.27 Mn
Dec 31, 2025 240,000.00
Sep 30, 2025 1.25 Mn
Jun 30, 2025 4.10 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 4.57 Mn
Sep 30, 2024 -2.89 Mn
Jun 30, 2024 -254,000.00
Mar 31, 2024 1.72 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.82 Mn
Jun 30, 2023 -132,000.00
Mar 31, 2023 1.94 Mn
Dec 31, 2022 -939,000.00
Sep 30, 2022 -2.44 Mn
Jun 30, 2022 5.32 Mn
Mar 31, 2022 -3.46 Mn
Dec 31, 2021 1.35 Mn
Sep 30, 2021 692,000.00